Rekom Biotech is listed as one of the top ten leading vendors in the Insight Partners' Viral Antigens Market Forecast to 2027 report
News
09/01/21
The Insight Partners makes reports that provide in-depth analysis on the selected topic, making a review of the most important companies in the sector, and restraints and opportunities available in the market.
The Viral Antigens Market Forecast to 2027 report provides a study of Viral Antigens market using SWOT analysis (Strength, Weakness, Opportunities and Threat to the organization), and also provides an in-depth survey of the key players in the market. This survey is based on various objectives of an organization, such as profiling, the product outline, the quantity of production, required raw material, and the financial health of the organization. Rekom Biotech appears as one of the ten top leading vendors of the Viral Antigens market.
This report also evaluates the COVID-19 impact and makes a global analysis:
By component:
Influenza Viral Antigens
Coronavirus Antigens
Zika Virus Antigens
Ebola Virus Antigens
Dengue Virus Antigens
Herpes Simplex Virus (HSV) Antigens
Rotavirus Viral Antigens
Hepatitis A-E Virus Antigens
Measles Virus Antigens
Mumps/Parotitis Virus Antigens
and Others
By technique:
ELISA
Immunoassay
Hemagglutination
Radioimmunoassay (RIA)
Immunoperoxidase Staining
Immunofluorescence
and Others
By end-user:
Hospitals
Clinics
Laboratories
Diagnostic Centers
Blood Banks
Research Institutes
And by geography
For more information, please visit https://www.theinsightpartners.com/reports/viral-antigens-market.